Rpharmy Blog

Your Assessment of Risk is Done. Now What?

Posted by Rpharmy Marketing on Oct 20, 2021 12:01:38 PM

Congratulations! We mean that sincerely. It is no easy feat to complete an Assessment of Risk (AoR) for a single hazardous drug much less the hundreds of HDs you use within your facility that require this level of documentation. So, now what? 

Read More

Topics: Rhazdrugs, Policy, USP <800>, FormWeb

Stranded Between NIOSH 2016 and NIOSH 2020

Posted by Rpharmy Marketing on Oct 5, 2021 8:41:23 AM

Is your organization still working off of the NIOSH 2016 hazardous drug (HDs) list? If so, no need to hang your head. You’re not alone... and not by a long shot. Because NIOSH 2020 is not the law of the land yet, many healthcare facilities are still abiding by the 2016 list. 

Read More

Topics: Rhazdrugs, Policy, USP <800>, FormWeb

Medical Surveillance: What Human Cost are You Willing To Pay?

Posted by Rpharmy Marketing on Sep 20, 2021 11:14:29 AM

As a new patient, what is the first thing your doctor’s office usually gathers from you? Baseline labs and tests so they can understand your current health conditions, medical history and track your health moving forward. This same approach, called medical surveillance, should be used by healthcare organizations to monitor healthcare professionals who handle hazardous drugs in hopes of successfully minimizing adverse health effects and preventing devastating illness.  

Read More

Topics: Rhazdrugs, Policy, USP <800>, FormWeb

USP <800> Inspectors are Coming: Are you Ready?

Posted by Rpharmy Marketing on Aug 4, 2021 7:04:47 AM

After a bit of a reprieve due to COVID, how prepared do you feel when an inspector shows up at your door? Across the country, our clients are either already undergoing inspections or are preparing for them to start up again. 

Read More

Topics: Rhazdrugs, Policy, USP <800>, FormWeb

Part 2: Eight Components Of An Effective Hazardous Drugs Communication Plan

Posted by Rpharmy Marketing on Jul 19, 2021 2:44:57 PM

In part 1, we talked about the basics of how to best communicate hazardous drugs safety information including making the guidelines accessible, searchable, and understandable. By ensuring these basics are covered you’ve drastically increased the chances that your healthcare workers will use the safety information and that their health and well-being will be protected. 

Read More

Topics: Rhazdrugs, Policy, USP <800>, FormWeb

Eight Components Of An Effective Hazardous Drugs Communication Plan, Part 1 Of 2

Posted by Rpharmy Marketing on Jul 13, 2021 8:00:25 AM

Like a seatbelt, a hazardous drugs communication plan is a layer of protection from potentially life-altering or deadly hazardous exposure. Most healthcare organizations meet current regulations by providing hazardous drugs handling and disposal information in physical binders or on their SharePoint intranet. However, even adhering to basic standards, this vital information is not easy to get your hands on when treating a patient or disposing of hazardous drugs or materials. 

Read More

Topics: Rhazdrugs, Policy, USP <800>, FormWeb

Patients Reap Rewards from Healthcare’s Increased Investment in Specialty Pharmacy

Posted by Rpharmy Marketing on May 19, 2021 3:47:54 PM

Throughout the COVID-19 public health crisis, hospitals and other surgical centers lost a major revenue stream in the form of elective surgeries. However, federal COVID relief funds, traditional investments in commercial real estate and a rise in investments in healthcare tech like specialty pharmacy, have helped to fill in the revenue gaps. 

Read More

Topics: Rhazdrugs, Policy, USP <800>, FormWeb

Rpharmy Receives Woman-Owned Business Certification

Posted by Rpharmy Marketing on Apr 27, 2021 9:55:51 AM

I am extremely proud to proclaim that Rpharmy is a Certified Woman-Owned Business! This recognition is a reflection of my passion for entrepreneurship and gives a well-deserved stamp of approval to Rpharmy and all the work we put into improving patient and healthcare safety.

Read More

Topics: Rhazdrugs, Policy, USP <800>, FormWeb

Meet Rpharmy's Sherrel Miller

Posted by Rpharmy Marketing on Apr 14, 2021 8:28:48 AM

Let us introduce you to one of our outstanding Rpharmy team members, Sherrel Miller. She works both behind the scenes doing the vital work of maintaining the safety databases including Black Box Warnings, FDA REMS, FDA Patient Medication Guides and FDA Safety Alerts AND she’s out in front taking great care of our FormWeb customers.

Read More

Topics: Rhazdrugs, Policy, USP <800>, FormWeb

Rpharmy Wishes Lynn Huggins Much Luck in Next Chapter

Posted by Rpharmy Marketing on Apr 5, 2021 1:11:51 PM

We’ve got that mixed-emotions thing going on here at Rpharmy. After 16 years, our dear friend Lynn Huggins is retiring. While we are happy for the adventures yet to come for Lynn, we’re not sure what Rpharmy looks like without her; she’s been with us since the beginning. 

Read More

Topics: Rhazdrugs, Policy, USP <800>, FormWeb

New Name

Same Company You Trust

Rpharmy has a suite of products to meet the diverse needs of our customers.

Subscribe Here!

Recent Posts